Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety Pilot Study of Px-104 in Non-alcoholic Fatty Liver Disease (NAFLD) Patients

NCT01999101 is registered in ClinicalTrials.gov with Phenex Pharmaceuticals AG as lead sponsor.

NCT NCT01999101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety Pilot Study of Px-104 in Non-alcoholic Fatty Liver Disease (NAFLD) Patients
Lead sponsor
Phenex Pharmaceuticals AG
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
June 30, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non alcoholic fatty liver disease